BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20226185)

  • 1. Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease.
    Banerjee K; Sinha M; Pham Cle L; Jana S; Chanda D; Cappai R; Chakrabarti S
    FEBS Lett; 2010 Apr; 584(8):1571-6. PubMed ID: 20226185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.
    Bir A; Sen O; Anand S; Khemka VK; Banerjee P; Cappai R; Sahoo A; Chakrabarti S
    J Neurochem; 2014 Dec; 131(6):868-77. PubMed ID: 25319443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells.
    Parihar MS; Parihar A; Fujita M; Hashimoto M; Ghafourifar P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):2015-24. PubMed ID: 19460457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease.
    Bharathi ; Rao KS
    Biochem Biophys Res Commun; 2007 Jul; 359(1):115-20. PubMed ID: 17531952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity.
    Liu G; Zhang C; Yin J; Li X; Cheng F; Li Y; Yang H; Uéda K; Chan P; Yu S
    Neurosci Lett; 2009 May; 454(3):187-92. PubMed ID: 19429081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.
    Furukawa K; Matsuzaki-Kobayashi M; Hasegawa T; Kikuchi A; Sugeno N; Itoyama Y; Wang Y; Yao PJ; Bushlin I; Takeda A
    J Neurochem; 2006 May; 97(4):1071-7. PubMed ID: 16606366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator.
    Zhu Y; Duan C; Lü L; Gao H; Zhao C; Yu S; Uéda K; Chan P; Yang H
    Int J Biochem Cell Biol; 2011 May; 43(5):732-41. PubMed ID: 21310263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
    Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN
    J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE; Wersinger C; Tomita Y; Sidhu A
    Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging promotes amyloid-β peptide induced mitochondrial dysfunctions in rat brain: a molecular link between aging and Alzheimer's disease.
    Sinha M; Behera P; Bhowmick P; Banerjee K; Basu S; Chakrabarti S
    J Alzheimers Dis; 2011; 27(4):753-65. PubMed ID: 21876248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.